Skip to main content
Difficulty falling asleep and/or staying asleep is common among transplant recipients. The usual solutions recommended – sleep hygiene, medication – are less effective than cognitive behavioral therapy for insomnia. Learn what defines a good night’s sleep and how to get it.
A pediatric bone marrow transplant can cure a child’s disease, but it can also create a number of physical, emotional and financial issues that need to be addressed, even when the child becomes an adult. This presentation discusses common challenges children face after transplant, and strategies to provide them with a good quality of life long-term.
CAR T-cell therapy is new treatment option for patients with certain types of non-Hodgkin lymphoma, acute lymphoblastic leukemia and multiple myeloma who relapsed or did not respond to other treatments. This presentation discusses who is eligible to receive CAR T-cell therapy, what the procedure entails and potential side effects.
Fatigue is the most common complaint of patients. It can continue for years after treatment. It may be due to the disease itself, or the chemotherapy, radiation, and other medications used to treat the disease. This presentation reviews the causes and complications of transplant-related fatigue and describes lifestyle changes and pharmacological interventions that can improve cancer-related fatigue.
Herbs and supplements have become popular with the public as well as cancer patients. Because they are unregulated, however, their safety and efficacy are difficult to judge. This presentation reviews the most common herbs and supplements and summarizes what is known about their benefits and risks for transplant recipients.
Cancer-related fatigue affects up to 80% of cancer survivors. Exercise is the best “medicine” and can resolve many symptoms of fatigue. This presentation provides detailed advice on how transplant recipients can use exercise to improve their quality of life.
Caregiving for transplant recipients is a demanding task for which there is little preparation. Caregivers face practical, emotional, and social challenges caring for transplant recipients while also maintaining their own roles. This presentation discusses caregiver challenges and offers some methods for meeting them.
Transplant recipients face several risks to long-term heart health arising from their cancer treatment. This presentation identifies these risks and offers strategies to minimize them and foster healthy, long-term survival.
Multiple myeloma is the most common cancer of the bone marrow. This presentation discusses transplant options and drug therapies for treating myeloma. It also reviews options for maintenance therapy and responding to relapses.
Autologous stem cell transplants use the patient’s own stem cells to rescue him or her from the effects of high-dose chemotherapy. This type of transplant is most often used to treat patients with multiple myeloma, non-Hodgkin lymphoma and Hodgkin lymphoma. This presentation discusses the transplant process, and common early and late complications.